<?xml version="1.0" encoding="UTF-8"?>
<p class="p">
 <italic class="italic">P. integerrima</italic> presented potential antiasthmatic activity in preclinical studies. This activity is related to inhibition of the degranulation of mast cell and inhibition of 5-LOX, where treatment with EO considerably reduced the number of total leukocytes in bronchoalveolar lavage fluid and pulmonary levels of myeloperoxidase. Associated with this, the plant presented antioxidant potential in the DPPH test, indicating satisfactory results for the treatment of chronic pulmonary diseases with possible involvement of oxidative pathways [
 <xref rid="B31" ref-type="bibr" class="xref">31</xref>].
</p>
